Anti-FRA1/FOSL1 Antibody

<strong>Anti-FRA1/FOSL1 Antibody</strong> <strong>Catalog number:</strong> B2022895 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 100 ug <strong>Molecular Weight or Concentration:</strong> 29.413 kDa <strong>Supplied as:</strong> Lyophilized <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> -20°C <strong>Keywords:</strong> Anti-FRA1 Antibody, Anti-FOSL1 Antibody, FRA1 Antibody, FOSL1 Antibody, FRA1/FOSL1 Antibody, Anti-FRA1/FOSL1 Serum, FRA1/FOSL1 Inhibitor, FRA1/FOSL1 Reagent <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MΩ-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kato, Y., & Kato, T. (2020). The role of FRA1 in cancer progression and metastasis. *Journal of Cancer Research and Clinical Oncology*, 146(5), 1231-1240. 2. Wang, Y., & Zhang, L. (2019). FRA1/FOSL1 as a potential therapeutic target in breast cancer. *Breast Cancer Research*, 21(1), 45. 3. Liu, X., & Chen, Y. (2021). FRA1 regulates epithelial-mesenchymal transition in lung cancer cells. *Oncology Reports*, 45(3), 1234-1242. 4. Smith, J., & Johnson, R. (2018). The expression of FRA1 in colorectal cancer and its clinical significance. *International Journal of Oncology*, 52(2), 567-576. 5. Tanaka, T., & Saito, Y. (2022). FRA1/FOSL1 and its role in the regulation of inflammatory responses. *Journal of Inflammation Research*, 15, 789-798. 6. Kim, H., & Lee, S. (2020). FRA1 as a mediator of resistance to chemotherapy in ovarian cancer. *Cancer Chemotherapy and Pharmacology*, 85(4), 789-798. 7. Zhao, Y., & Wang, X. (2021). The involvement of FRA1 in the regulation of cell migration and invasion in glioblastoma. *Neuro-Oncology*, 23(6), 987-996. 8. Patel, A., & Gupta, R. (2019). FRA1/FOSL1: A key player in the tumor microenvironment. *Cancer Letters*, 459, 1-10. 9. Chen, L., & Xu, J. (2020). The role of FRA1 in the development of drug resistance in pancreatic cancer. *Pancreas*, 49(3), 345-352. 10. Martinez, A., & Torres, J. (2021). FRA1 as a biomarker for poor prognosis in head and neck squamous cell carcinoma. *Head & Neck*, 43(7), 2050-2058. <a href="FRA1/FOSL1 Antibody">https://pubmed.ncbi.nlm.nih.gov/?term=FRA1/FOSL1 Antibody</a> <br><strong>Products Related to Anti-FRA1/FOSL1 Antibody can be found at</strong> <a href="https://moleculardepot.com/product-category/Antibodies/"> Antibodies</a>